BioCentury
ARTICLE | Company News

J&J's Comfyde gets complete response

August 22, 2009 12:57 AM UTC

Johnson & Johnson (NYSE:JNJ) received a complete response letter from FDA for Comfyde carisbamate for the adjunctive treatment of partial onset seizures in patients 16 years and older. Details of the ...